NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a draft guidance document that aims to make it easier to get oncology-class labeling on companion diagnostic tests for therapeutic products.

Broadly, the initiative aims to address labeling challenges associated with developing companion diagnostics that can help target the delivery of cancer drugs, FDA Commissioner Scott Gottlieb said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.